Associations of Vitamin D, Parathyroid Hormone and Calcium with Cardiovascular Risk Factors in US Adolescents

Overview

Journal Heart

Date 2011 Jan 4

PMID 21193684

Citations 18

Authors

Dylan M Williams

Abigail Fraser

Debbie A Lawlor

Affiliations

Soon will be listed here.

Abstract

Objective: To examine independent associations of serum 25-hydroxyvitamin D (25(OH)D), parathyroid hormone (PTH) and calcium with a range of cardiovascular risk factors in adolescents.

Design: Cross-sectional population-based study.

Setting: A nationally representative sample of the US adolescent population.

Participants: Healthy adolescents (aged 12-19) participating in the National Health and Nutrition Examination Survey (NHANES) between 2001 and 2006. Numbers varied between 740 and 5609 for given exposure and outcome associations.

Main Outcome Measures: Systolic blood pressure (SBP), diastolic blood pressure (DBP), lipids (triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C)), fasting insulin and glucose, postload glucose and glycohaemoglobin (HbA1c).

Results: 25(OH)D was inversely associated with SBP (-0.068 standard deviations (SD), 95% CI -0.118 to -0.018), and positively associated with HDL-C (0.101; 0.040 to 0.162) and HbA1c (0.073; 0.021 to 0.125) after adjustment for gender, age, ethnicity, socioeconomic status and waist circumference. In adjusted models, PTH was inversely associated with triglycerides (-0.115; -0.188 to -0.042) and LDL-C (-0.133; -0.207 to -0.060). In adjusted models, calcium was positively associated with fasting insulin (0.110; 0.060 to 0.160), postload glucose (0.116; 0.000 to 0.232), HbA1c (0.079; 0.035 to 0.123), triglycerides (0.182; 0.122 to 0.242), HDL-C (0.049; 0.010 to 0.088) and LDL-C (0.137; 0.080 to 0.195). The associations of each exposure with risk factors remained after mutual adjustment for each other.

Conclusion: Higher calcium levels might be a more important predictor of increased cardiovascular risk in adolescents than lower 25(OH)D levels or PTH levels, but the findings require replication in additional studies and examination in prospective studies.

Citing Articles

A cohort study of serum 25-hydroxyvitamin D levels and the risk of hyperlipidaemia in adults.

Liu Z, Liu S, Yao X, Wang C, Song Y, Bi Y Front Nutr. 2025; 11:1492621.

PMID: 39925969 PMC: 11802281. DOI: 10.3389/fnut.2024.1492621.

Vitamin D and Dyslipidemia: Is There Really a Link? A Narrative Review.

Al Refaie A, Baldassini L, Mondillo C, De Vita M, Giglio E, Tarquini R Nutrients. 2024; 16(8).

PMID: 38674837 PMC: 11053479. DOI: 10.3390/nu16081144.

The unique association between serum 25-hydroxyvitamin D concentrations and blood lipid profiles in agriculture, forestry, and fishing occupations: Insights from NHANES 2001-2014.

Zhang B, Dong X PLoS One. 2024; 19(2):e0297873.

PMID: 38412162 PMC: 10898752. DOI: 10.1371/journal.pone.0297873.

Vitamin D status and blood pressure in children and adolescents: a systematic review of observational studies.

Abboud M, Al Anouti F, Papandreou D, Rizk R, Mahboub N, Haidar S Syst Rev. 2021; 10(1):60.

PMID: 33618764 PMC: 7898425. DOI: 10.1186/s13643-021-01584-x.

Usefulness of Serum Calcium in the Risk Stratification of Midterm Mortality among Patients with Acute Coronary Syndrome.

Gu X, Ding X, Sun H, Chen N, Liu D, Sun D Biomed Res Int. 2019; 2019:9542054.

PMID: 31781656 PMC: 6875235. DOI: 10.1155/2019/9542054.

References

Pfeifer M, Begerow B, Minne H, Nachtigall D, Hansen C . Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001; 86(4):1633-7. DOI: 10.1210/jcem.86.4.7393. View

Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S . Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol. 1997; 50(8):967-73. DOI: 10.1016/s0895-4356(97)00104-2. View

Hagstrom E, Hellman P, Larsson T, Ingelsson E, Berglund L, Sundstrom J . Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009; 119(21):2765-71. DOI: 10.1161/CIRCULATIONAHA.108.808733. View

Zittermann A, Frisch S, Berthold H, Gotting C, Kuhn J, Kleesiek K . Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009; 89(5):1321-7. DOI: 10.3945/ajcn.2008.27004. View

Norman A, Frankel J, Heldt A, GRODSKY G . Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980; 209(4458):823-5. DOI: 10.1126/science.6250216. View

Krause R, Buhring M, Hopfenmuller W, Holick M, Sharma A . Ultraviolet B and blood pressure. Lancet. 1998; 352(9129):709-10. DOI: 10.1016/S0140-6736(05)60827-6. View

Reis J, von Muhlen D, Miller 3rd E, Michos E, Appel L . Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics. 2009; 124(3):e371-9. PMC: 4222068. DOI: 10.1542/peds.2009-0213. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Wang Y, Jacobs E, McCullough M, Rodriguez C, Thun M, Calle E . Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d. Am J Epidemiol. 2009; 170(1):88-94. DOI: 10.1093/aje/kwp086. View

10.

Snijder M, van Dam R, Visser M, Deeg D, Dekker J, Bouter L . Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab. 2005; 90(7):4119-23. DOI: 10.1210/jc.2005-0216. View

11.

Wang T, Pencina M, Booth S, Jacques P, Ingelsson E, Lanier K . Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117(4):503-11. PMC: 2726624. DOI: 10.1161/CIRCULATIONAHA.107.706127. View

12.

Brot C, Jorgensen N, Madsen O, Jensen L, Sorensen O . Relationships between bone mineral density, serum vitamin D metabolites and calcium:phosphorus intake in healthy perimenopausal women. J Intern Med. 1999; 245(5):509-16. DOI: 10.1046/j.1365-2796.1999.00474.x. View

13.

Prentice A, Goldberg G, Schoenmakers I . Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr. 2008; 88(2):500S-506S. DOI: 10.1093/ajcn/88.2.500S. View

14.

Hofmann J, Yu K, Horst R, Hayes R, Purdue M . Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev. 2010; 19(4):927-31. PMC: 2857993. DOI: 10.1158/1055-9965.EPI-09-1121. View

15.

Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2):229-38. PMC: 151055. DOI: 10.1172/JCI15219. View

16.

Krabbe S, Christiansen C, Hummer L . Serum vitamin D metabolites are not related to growth rate, bone mineral content, or serum alkaline phosphatase in male puberty. Calcif Tissue Int. 1986; 38(3):127-9. DOI: 10.1007/BF02556871. View

17.

McCarron P, Smith G, Okasha M, McEwen J . Blood pressure in young adulthood and mortality from cardiovascular disease. Lancet. 2000; 355(9213):1430-1. DOI: 10.1016/S0140-6736(00)02146-2. View

18.

Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen M, Montonen J . Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007; 30(10):2569-70. DOI: 10.2337/dc07-0292. View

19.

Forman J, Giovannucci E, Holmes M, Bischoff-Ferrari H, Tworoger S, Willett W . Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007; 49(5):1063-9. DOI: 10.1161/HYPERTENSIONAHA.107.087288. View

20.

Tylavsky F, Ryder K, Lyytikainen A, Cheng S . Vitamin D, parathyroid hormone, and bone mass in adolescents. J Nutr. 2005; 135(11):2735S-8S. DOI: 10.1093/jn/135.11.2735S. View